| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | $3.00M | $2.96M | $2.90M | $4.98M | $20.31M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $46.00K | $497.00K | $132.00K | – | – |
| R&D | – | – | – | – | – |
| SG&A | $596.00K | $481.00K | $505.00K | $505.00K | $160.00K |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | $11.46M | $4.91M | $2.40M | $4.42M |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$13.74M | -$2.98M | -$4.40M | -$847.00K | -$3.90M |
| EPS (basic) | -2.6500 | -0.6100 | -1.0300 | -0.2400 | -1.1400 |
| EPS (diluted) | -2.6500 | -0.6100 | -1.0300 | -0.2400 | -1.1400 |
| Shares (diluted) | $5.18M | $4.85M | $4.28M | $3.59M | $3.42M |